Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Moon

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Alimentary Pharmacology & Therapeutics|June 8, 2018
Review article: Asia-Pacific consensus recommendations on endoscopic tissue acquisition for biliary stricturesB Sun, J H Moon, Q Cai, et al.
Bone Marrow Transplantation|March 2, 2010
Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onsetJ H Moon, S N Kim, B W Kang, et al.
Cancer Research|February 1, 1971
Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemiaB Jones, J F Holland, A R Morrison, et al.
Genes|May 28, 2022
The Modified Shields Classification and 12 Families with Defined <i>DSPP</i> MutationsJames P Simmer, Hong Zhang, Sophie J H Moon, et al.
Free Radical Biology & Medicine|August 1, 2016
Corrigendum to 'L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells': [Free Radic. Biol. Med. 95 (2016) 200-208]S A Jung, D H Lee, J H Moon, et al.
Oncogene|May 31, 2016
Foxp3 is a key downstream regulator of p53-mediated cellular senescenceJ-E Kim, J-S Shin, J-H Moon, et al.
Leukemia|January 17, 2017
The clonal origins of leukemic progression of myelodysplasiaT Kim, M S Tyndel, H J Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2010
Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patientsM K Kim, C Suh, D H Lee, et al.
Cell Death and Differentiation|October 22, 2013
p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTENS-W Hong, J-H Moon, J-S Kim, et al.
Oncogene|June 6, 2012
SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatmentS-W Hong, S-H Lee, J-H Moon, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Alimentary Pharmacology & Therapeutics|June 8, 2018
Review article: Asia-Pacific consensus recommendations on endoscopic tissue acquisition for biliary stricturesB Sun, J H Moon, Q Cai, et al.
Bone Marrow Transplantation|March 2, 2010
Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onsetJ H Moon, S N Kim, B W Kang, et al.
Cancer Research|February 1, 1971
Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemiaB Jones, J F Holland, A R Morrison, et al.
Genes|May 28, 2022
The Modified Shields Classification and 12 Families with Defined <i>DSPP</i> MutationsJames P Simmer, Hong Zhang, Sophie J H Moon, et al.
Free Radical Biology & Medicine|August 1, 2016
Corrigendum to 'L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells': [Free Radic. Biol. Med. 95 (2016) 200-208]S A Jung, D H Lee, J H Moon, et al.
Oncogene|May 31, 2016
Foxp3 is a key downstream regulator of p53-mediated cellular senescenceJ-E Kim, J-S Shin, J-H Moon, et al.
Leukemia|January 17, 2017
The clonal origins of leukemic progression of myelodysplasiaT Kim, M S Tyndel, H J Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2010
Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patientsM K Kim, C Suh, D H Lee, et al.
Cell Death and Differentiation|October 22, 2013
p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTENS-W Hong, J-H Moon, J-S Kim, et al.
Oncogene|June 6, 2012
SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatmentS-W Hong, S-H Lee, J-H Moon, et al.
Pageof 11